Chemotherapy causes and spreads cancer

 

http://www.naturalnews.com/2017-08-14-chemotherapy-causes-cancer-science-study-finds-confirming-big-pharmas-repeat-business-model-for-cancer-patients.html

A new study that was just published in the journal Science Translational Medicine reveals chemotherapy increases the number of cancer cells circulating in the body and in the lungs. The chemotherapy drugs not only created new cancers, but spread them to other parts of the body where they are nearly always lethal.

Patients with breast cancer who are given chemotherapy drugs prior to surgery shrink their breast tumors in the short run while triggering the spread of deadly cancer around the body.

Advertisements

More Doctors Confessing To Intentionally Diagnosing Healthy People With Cancer To Make Money

Read more: http://www.antinewsnetwork.com/doctors-confessing-intentionally-diagnosing-healthy-people-cancer-make-money/

It happens more often than you can imagine, but more doctors are finally getting caught in the act of misrepresenting their oath and fraudulently diagnosing healthy patients with cancer to turn a quick buck from kickbacks on chemotherapy poisons.

Why shouldn’t Doctors lie when the entire cancer industry is one gigantic fabrication from start to finish? 

Is it any wonder that cancer societies worldwide put a far greater financial initiative on chemotherapy and radiation research than disease prevention techniques? Preventing disease doesn’t make money, but treating disease certainly does.

Take Dr. Farid Fata, a prominent cancer doctor in Michigan who admitted in court one year ago to intentionally and wrongfully diagnosing healthy people with cancer. Fata also admitted to giving them chemotherapy drugs for the purpose of making a profit.

Were his patients shocked? You bet they were. Who would ever suspect a Doctor of faking a diagnosis to collect money. It’s unconscionable. Yet it happens with cancer and almost every disease that medical doctors can generate income through kickbacks and commissions based on the volume of patients treated with specific pharmaceuticals. Like anything people are used as a comodity.

“Many of these unscrupulous Physicians are like businessmen without a conscience. The only difference is they have your health and trust in their hands–a very dangerous combination when money is involved,” said Dr. Sayed Mohammed, a retired Oncologist who admits seeing the trend more than a decade ago.

“It is my choice,” Fata said on Tuesday of his surprise guilty plea, which included rattling off the names of numerous drugs he prescribed for his patients over the years. In each admission, he uttered these words:

“I knew that it was medically unnecessary.”

Fata was charged with running a $35-million Medicare fraud scheme that involved billing the government for medically unnecessary oncology and hematology treatments. 

The government says Fata ran the scheme from 2009 to the present, through his medical businesses, including Michigan Hematology Oncology Centers, with offices in Clarkston, Bloomfield Hills, Lapeer, Sterling Heights, Troy and Oak Park.

According to the government, Fata had a patient load of 1,200 people and received $62 million from Medicare; he billed for more than $150 million.

 

 

 

Yet again, research shows chemo can make your cancer worse

Yet again, research shows chemo can make your cancer worse

Source: https://www.canceractive.com/cancer-active-page-link.aspx?n=3926&Title=Yet%20again,%20research%20shows%20chemo%20can%20make%20your%20cancer%20worse

Chemotherapy can actually encourage cancer spread, according to new research findings (1) by a team of scientists from the Albert Einstein College of Medicine in New York.

Dr. George Karagiannis, Jessica Pastoriza, and others from Departments of oncology, surgery, pathology and radiology studied breast cancer patients and showed that while chemotherapy could ‘knock back’ a cancer tumour by killing some cancer cells, it could also make matters far worse by encouraging cancer spread (increasing metastases). It is metastases that limit survival times and cause death.

The study was done in mice which had been given breast cancer, but the system found by which cancer cells started to metastasise was identical to that proven clinically in humans.

Cancer cells leaving tumours were already known get into the blood supply through special ‘doors’ called Tumour Microenvironment of Metastasis (TMEM). This new research showed that chemotherapy actually increased the number of doors, increased the activity through them and promoted distant metastases in the body.

Chris Woollams, former Oxford University Biochemist and founder of CANCERactive said, “This research is damning of chemotherapy, especially as it is not the first study to make this claim.

Drug companies and charities such as Cancer Research simply cannot wriggle out of these findings by looking at this research in isolation and/or claiming that this was shown in mice not humans, because TMEM is proven to be exactly the system in humans too.

This is now about the fourth time in the last 5 years that Chemotherapy has been shown to actually encourage cancer growth – to make matters worse. For example, Fred Hutchinson Cancer Research Center in Seattle showed in 2012 that chemotherapy also attacked ‘fibroblasts’ next to the cancer cells and these released a protein, WNT16B, that could be then used by cancer cells to protect themselves from further chemotherapy, increase growth and increase invasion rates. It talked about chemotherapy ‘Backfiring’ – or making matters worse (2). A similar result.

And it is not just ‘Old fashioned Chemotherapy’ that can be blamed. As anyone with breast cancer who has had a Personal Prescription with me will know, I am extremely concerned about Paclitaxel (Taxol) because it has been shown to CAUSE metastases too! A paper (extract 6014) presented at the 27th Annual San Antonio Breast Cancer SymposiumGerman researchers from the Friedrich-Schiller University in Jena found that the action of Taxol causes a massive increase in metastases around the body, which could appear as cancer some years after treatment had finished (3). 

The problem is simple. These drugs are chemical toxins. Too often their performance is simply compared against the performance of existing drug combinations. And that is inadequately measured by the ability to reduce tumour size.

The FDA has reported that anyway more than 40 per cent of Clinical Trials with drugs are inaccurate.

Meanwhile, cancer charities talk about increasing survival in a way that is totally meaningless to cancer patients. To Cancer Research UK it is an issue of extra days or weeks. To people with cancer it is an issue of beating cancer – of not having the disease any more. There is a complete lack of patient understanding going on.

We have only recently seen research from Oxford University showing that orthodox treatment for Prostate Cancer does not make a jot of difference to survival times (4). This too was the fourth such study. In any other business, the propagators of the over-claimed orthodox treatment usage, if they continued after such a finding, would be sued for fraud.

At least reason and honesty is starting to come through in the Medical Profession. The Academy of the Royal Medical Colleges in the UK talked of drugs for palliative care ‘creating false hope’ and ‘doing more harm than good’ (5), while NICE withdrew four out of every five drugs used in the Government special Chemotherapy fund, ‘because they didn’t work’. Even the Queen’s Doctor and former-President of the Royal College of Physicians, along with six other top Doctors, has talked of the heavy and negative influence of Big Pharma on Public Health (6) providing ‘useless and sometimes harmful drugs’. 

Frankly, the current situation on chemotherapy and other drugs is a mess and it needs a completely independent body to come in and sort it out because leading cancer charities, Health Authorities and Western Governments are all infiltrated by the misleading propaganda machine – from pharmaceutical companies to skeptics – and the power, fraud and corruption, a $70 billion market brings. 

Cancer drug treatments are letting the patients down, and the taxpayers too”.

Go To: 

1. http://stm.sciencemag.org/content/9/397/eaan0026

2. https://www.canceractive.com/cancer-active-page-link.aspx?n=3266

3. https://www.canceractive.com/cancer-active-page-link.aspx?n=2562

4. https://www.canceractive.com/cancer-active-page-link.aspx?n=3837&Title=Study%20finds%20no%20survival%20advantage%20in%20prostate%20treatment

5. https://www.canceractive.com/cancer-active-page-link.aspx?n=3852&Title=Chemotherapy%20gives%20‘False%20hope’%20and%20can%20‘do%20more%20harm%20than%20good’

6. http://www.junkscience.co.uk/2016/02/junk-science-number-92-big-pharma-providing-useless-and-sometimes-harmful-drugs/

 

New study finds a high blood platelet count is ‘strong predictor’ of cancer

LONDON, May 24 — A new UK study has revealed the first new strong indicator of cancer in 30 years, finding that having a high blood platelet count can predict who will go on to be diagnosed with cancer, and the researchers urge that it should be used by doctors in order to try to catch the disease early.

Known as thrombocytosis, up to half a million people (two per cent) of those over the age of 40 in the UK have a raised blood platelet count, with around 1 per cent of the general population developing cancer each year.

Led by the University of Exeter Medical School, the large-scale study is the first to thoroughly investigate the association between thrombocytosis and cancer, looking at 40,000 patient records in the UK.

The team found that 11per cent of men and 6per cent of women over the age of 40 with thrombocytosis went on to be diagnosed with cancer within a year.

This number rose to 18per cent of men and 10per cent of women being diagnosed with cancer if a second raised platelet count was found within six months.

The most commonly diagnosed cancers after a thrombocytosis diagnosis were lung and colourectal cancer, and one third of these patients had no other symptoms that would indicate to their GP that they had cancer — except for thrombocytosis.

The team are now urging GPs to consider that those with unexpected thrombocytosis may go on to also be diagnosed with cancer, in order to try to catch the disease early on.

“We know that early diagnosis is absolutely key in whether people survive cancer. Our research suggests that substantial numbers of people could have their cancer diagnosed up to three months earlier if thrombocytosis prompted investigation for cancer.

This time could make a vital difference in achieving earlier diagnosis,” commented lead author Dr Sarah Bailey, of the University of Exeter Medical School.

Professor Willie Hamilton, of the University of Exeter Medical School, also added that, “The UK lags well behind other developed countries on early cancer diagnosis. In 2014, 163,000 people died of cancer in this country.

“Our findings on thrombocytosis show a strong association with cancer, particularly in men — far stronger than that of a breast lump for breast cancer in women. It is now crucial that we roll out cancer investigation of thrombocytosis. It could save hundreds of lives each year.”

The paper can be found online published in the British Journal of General Practice— AFP-Relaxnews

 Note: At CA Care we have been using your Platelets Count as a monitor for cancer since the past twenty years!

– See more at: http://www.themalaymailonline.com/features/article/new-study-finds-a-high-blood-platelet-count-is-strong-predictor-of-cancer#sthash.I1bcR7Ob.dpuf

Exercise more effective than meds at relieving fatigue for cancer patients

Psychological interventions, such as therapy to help change personal behavior and the way a person thinks about his or her circumstances, also had a similar, beneficial effect.

Exercise could be a more effective way of reducing cancer-related fatigue than medications suggests new research published this week in JAMA Oncology.

Led by the Wilmot Cancer Institute at the University of Rochester in the state of New York, the study analyzed more than 11,000 patients across 113 unique studies that tested various treatments for cancer-related fatigue.

All were randomized clinical trials, the highest standard for evaluating effective treatments.

Nearly half of the studies’ participants were women with breast cancer, with ten studies focusing on other types of cancer and including only men.

All of the participants suffered cancer-related fatigue, the most common side effect during and after cancer treatment.

This type of fatigue is different from being chronically tired, explains lead author Karen Mustian, and is a “crushing” sensation that’s not relieved by rest or sleep and that can persist for months or even years.

Even more concerning, Mustian explained, is that this fatigue can decrease a patient’s chances of survival because sufferers are less likely to complete medical treatments, with the National Cancer Institute putting cancer-related fatigue as a top research priority.

After analyzing the data, Mustian and her team found that exercise alone — including both aerobic or anaerobic — had the most significant effect on reducing cancer-related fatigue.

Psychological interventions, such as therapy to help change personal behavior and the way a person thinks about his or her circumstances, also had a similar, beneficial effect.

However, perhaps surprisingly, studies which looked at a combination of exercise and psychological therapy had mixed results, with the researchers unable to say for sure what is the best combination of both to make them effective.

With exercise and/or psychological therapy working better than medications used for treating cancer-related fatigue, the team now believe that these methods should be recommended first to patients.

“The literature bears out that these drugs don’t work very well although they are continually prescribed,” commented Mustian, “Cancer patients already take a lot of medications and they all come with risks and side effects. So any time you can subtract a pharmaceutical from the picture it usually benefits patients.”

“If a cancer patient is having trouble with fatigue, rather than looking for extra cups of coffee, a nap, or a pharmaceutical solution, consider a 15-minute walk,” she suggested.

Mustian has been studying exercise and cancer alongside Wilmot colleagues for almost 15 years. Much or her work looks at gentle yoga, walking, resistance bands, and other forms of movement to help ease side effects.

http://www.freemalaysiatoday.com/category/leisure/2017/03/05/exercise-more-effective-than-meds-at-relieving-fatigue-for-cancer-patients/

 

1 in 4 males, and 1 in 5 females are likely to get cancer by 75 years old

From a Straits Times article by Ms Salma Khalik1, the National Registry of Diseases Office reported 13,241 cancer cases in 2014, with lung cancer being the deadliest type of cancer. Over a period of 5 years, from 2010 to 2014, out of 6,899 people diagnosed with lung cancer 5,732 died of it.

The incidence rate can be rather high for some types of cancer as shown in the table below, data from Singapore Cancer Society2.

Top 3 cancer by gender:

Men % Women %
Colorectal 17.2% Breast 29.2%
Lung 115.0% Colorectal 13.3%
Prostate 12.2% Lung 7.6%

A general word of advice, if you find anything unusual with your body, seek proper medical advice. The earlier the diagnosis and treatment of cancer (or any critical illness for that matter), the better your chances of making a good recovery.

For more:  http://www.straitstimes.com/singapore/health/more-people-getting-cancer-since-2010

 

 

 

Cancer doctor Ang Peng Tiam appeals against misconduct conviction

Dr Ang was fined $25,000 last year after a disciplinary tribunal found him guilty of two charges.

When a 55-year-old woman with lung cancer saw him in April 2010, prominent oncologist Ang Peng Tiam told her there was a “70 per cent chance” of the disease responding to treatment and achieving control with chemotherapy and targeted therapy.

Dr Ang, who is the medical director of Parkway Cancer Centre, did not offer her the option of surgery, which he felt was not viable in this case due to, among other things, the location of the fist-sized tumour.

The patient died six months later, after the cancer spread to other parts of her body, including her brain, liver and pancreas.

Her family complained about Dr Ang to the profession’s watchdog – the Singapore Medical Council (SMC) – which brought four charges against him for professional misconduct.

Last year, Dr Ang was fined $25,000 after a disciplinary tribunal found him guilty of two charges – for falsely representing to the patient her chances of a favourable response to his prescribed therapy and for failing to offer her the option of surgery. He was cleared of the other two charges.

Yesterday, Dr Ang, who is also chief executive of medical oncology firm TalkMed, appealed against his conviction before a Court of Three Judges.

The SMC cross-appealed, arguing that he should be suspended for at least six months per charge.

Dr Ang, represented by Senior Counsel Edwin Tong, argued that it was reasonable for him to cite a 70 per cent disease-control rate just based on chemotherapy alone.

He cited medical literature to support his assertion that the patient’s chances would be optimised by combining chemotherapy with anti-cancer drugs called tyrosine kinase inhibitors. This was because the patient had four characteristics – including having never smoked – and such patients have been shown to be highly responsive to the therapy, he argued.

As for surgery, Dr Ang argued that he had made a judgment call that it was not a viable treatment option. Surgery cannot guarantee the complete removal of the tumour, given its size and location, he said.

But the SMC’s lawyer Melanie Ho charged that Dr Ang’s statement on the 70 per cent chance was false as it is achievable only for patients who test positive for epidermal growth factor receptor mutation.

As he did not carry out the test, Dr Ang had no basis to promise a 70 per cent chance of shrinkage and control of the tumour, she said.

She noted that Dr Ang had not produced literature to support his contention of a 70 per cent chance based on chemotherapy alone.

Ms Ho argued that it was not for Dr Ang to decide on the treatment but to offer options. “It is the patient’s right to choose,” she said.

After nearly five hours of arguments, the court reserved judgment. A decision will be given at a later date.

selinal@sph.com.sg

– See more at: http://news.asiaone.com/news/singapore/cancer-doctor-ang-peng-tiam-appeals-against-misconduct-conviction#sthash.UqT14r6r.dpuf